ScholarIQanswers from OpenAlex & ORCID
Daniel J. Sargent
ResearcherPublications, citations & collaboration network
Daniel J. Sargent is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel J. Sargent have?
ScholarIQindexed works
Daniel J. Sargent has 773 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel J. Sargent have?
ScholarIQcitation count
Daniel J. Sargent has 87,610 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel J. Sargent?
ScholarIQh-index
Daniel J. Sargent has an h-index of 109 in OpenAlex.
What is the i10-index of Daniel J. Sargent?
ScholarIQi10-index
Daniel J. Sargent has an i10-index of 363 in OpenAlex.
What is the ORCID of Daniel J. Sargent?
ScholarIQorcid
The ORCID for Daniel J. Sargent is on the source record.
What is the OpenAlex record for Daniel J. Sargent?
ScholarIQopenalex
The OpenAlex for Daniel J. Sargent is on the source record.
What are the most-cited papers on Daniel J. Sargent?
ScholarIQmost cited works
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz, George J. Chang, Michael J. Overman, Cathy Eng, Daniel J. Sargent, David W. Larson, Axel Grothey, Jean‐Nicolas Vauthey, David M. Nagorney, Robert R. McWilliams
Guidelines 2000 for Colon and Rectal Cancer Surgery
H. Nelson, Nicholas J. Petrelli, Arthur M. Carlin, Jean Couture, J. Fleshman, José G. Guillem, Brent Miedema, Daisuke Ota, Daniel J. Sargent
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto Sobrero, Anthony F. Shields, Takayuki Yoshino, James Paul, Julien Taı̈eb, John Souglakos, Qian Shi, Rachel Kerr, Roberto Labianca, Jeffrey A. Meyerhardt, Déwi Vernerey, Takeharu Yamanaka, Ioannis Boukovinas, Jeffrey P. Meyers, Lindsay A. Renfro, Donna Niedzwiecki, Toshiaki Watanabe, Valter Torri, Mark Saunders, Daniel J. Sargent, Thierry André, Timothy Iveson
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes
James W. Fleshman, Megan E. Branda, Daniel J. Sargent, Anne Marie Boller, Virgilio George, Maher A. Abbas, Walter R. Peters, Dipen Maun, George J. Chang, Alan J. Herline, Alessandro Fichera, Matthew G. Mutch, Steven D. Wexner, Mark H. Whiteford, John H. Marks, Elisa H. Birnbaum, David A. Margolin, David W. Larson, Peter W. Marcello, Mitchell C. Posner, Thomas E. Read, John R.T. Monson, Sherry M. Wren, Peter W. T. Pisters, Heidi Nelson
Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841
Jan Franko, Qian Shi, Charles D. Goldman, Barbara A. Pockaj, Garth D. Nelson, Richard M. Goldberg, Henry C. Pitot, Axel Grothey, Steven R. Alberts, Daniel J. Sargent